You’d hope so but it’s also not the first data we’ve seen in mice - needs to go further imo.
Biggest thing is to be able to deliver pk/pd it’s been long elusive for PYC and had multiple biotech partnerships trying to improve it but still not quite getting there.
Any deal with big pharna putting down more than has been seen in the last 5 or 6 big pharma deals the company has had comes down to being able to improve that pk/pd imo
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.020(1.56%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.616M | 3.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19940 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 1008 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |